VICARIOUS SURGICAL INC-A (RBOT:NYSE)
$0.1075 -0.0021 (-1.9161%)
Analysed VICARIOUS SURGICAL INC-A (RBOT:NYSE) News Sources
Vicarious inks software partnership as it streamlines operations
06-01-2026
medtechdive.com
Vicarious Surgical receives NYSE delisting notice
04-03-2026
medtechdive.com
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
25-03-2026
yahoo.com
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
30-03-2026
yahoo.com
Vicarious Surgical Reports First Quarter 2026 Financial Results
30-04-2026
yahoo.com
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
13-05-2026
yahoo.com
SS Innovations names Sarah Romano as CFO
15-07-2026
medtechdive.com
Vicarious Surgical board proposes dissolving the company
15-07-2026
medtechdive.com
SS Innovations International (SSII) Appoints Sarah Romano as Chief Financial Officer
15-07-2026
yahoo.com
Time runs out for Vicarious Surgical
22-07-2026
medtechdive.com
What is the current price of VICARIOUS SURGICAL INC-A (RBOT:NYSE)?
The current price of VICARIOUS SURGICAL INC-A (RBOT:NYSE) is $0.1075.
VICARIOUS SURGICAL INC-A (RBOT:NYSE) absolute price change since previous trading day?
The absolute price change of VICARIOUS SURGICAL INC-A (RBOT:NYSE) since the previous trading day is $-0.0021.
VICARIOUS SURGICAL INC-A (RBOT:NYSE) percentage price change since previous trading day?
The percentage price change of VICARIOUS SURGICAL INC-A (RBOT:NYSE) since the previous trading day is -1.9161%.
What is the most recent average sentiment score for VICARIOUS SURGICAL INC-A (RBOT:NYSE)?
The most recent average sentiment score for VICARIOUS SURGICAL INC-A (RBOT:NYSE) is 72 out of 100.
What is the most recent average sentiment for VICARIOUS SURGICAL INC-A (RBOT:NYSE)?
The most recent sentiment for VICARIOUS SURGICAL INC-A (RBOT:NYSE) is .
SEC-8K** Filing Available For VICARIOUS SURGICAL INC-A (RBOT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.